Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, Badie J, Botoc NV, Brisard L, Bui HN, Chatellier D, Chauvelot L, Combes A, Cracco C, Darmon M, Das V, Debarre M, Delbove A, Devaquet J, Dumont LM, Gontier O, Groyer S, Guérin L, Guidet B, Hourmant Y, Jaber S, Lambiotte F, Leroy C, Letocart P, Madeux B, Maizel J, Martinet O, Martino F, Maxime V, Mercier E, Nay MA, Nseir S, Oziel J, Picard W, Piton G, Quenot JP, Reizine F, Renault A, Richecoeur J, Rigaud JP, Schneider F, Silva D, Sirodot M, Souweine B, Tamion F, Terzi N, Thévenin D, Thiery G, Thieulot-Rolin N, Timsit JF, Tinturier F, Tirot P, Vanderlinden T, Vinatier I, Vinsonneau C, Voicu S, Lascarrou JB, Le Gouge A; NUTRIREA-3 Trial Investigators; Clinical Research in Intensive Care; Sepsis (CRICS-TRIGGERSEP)Group. Reignier J, et al. Among authors: asfar p. Lancet Respir Med. 2023 Jul;11(7):602-612. doi: 10.1016/S2213-2600(23)00092-9. Epub 2023 Mar 20. Lancet Respir Med. 2023. PMID: 36958363 Clinical Trial.
Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study.
Raymond M, Le Thuaut A, Asfar P, Darreau C, Reizine F, Colin G, Dano C, Lorber J, Hourmant B, Delbove A, Frérou A, Morin J, Egreteau PY, Seguin P, Reignier J, Lascarrou JB, Canet E. Raymond M, et al. Among authors: asfar p. Ann Intensive Care. 2022 Oct 29;12(1):102. doi: 10.1186/s13613-022-01074-w. Ann Intensive Care. 2022. PMID: 36308564 Free PMC article.
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study.
Lamouche-Wilquin P, Perrin L, Pere M, Raymond M, Asfar P, Darreau C, Reizine F, Colin G, Delbove A, Auchabie J, Hourmant B, Frérou A, Combe B, Morin J, Kergoat P, Lorber J, Egreteau PY, Souchard J, Canet E, Lascarrou JB. Lamouche-Wilquin P, et al. Among authors: asfar p. Thromb J. 2023 Apr 18;21(1):42. doi: 10.1186/s12959-023-00491-6. Thromb J. 2023. PMID: 37072788 Free PMC article.
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, Salcedo-Magguilli M, Lemarié J, De Schryver N, Jalkanen V, Hicheur T, Garaud JJ, Cuvier V, Ferrer R, Bestle M, Pettilä V, Mira JP, Bouisse C, Mercier E, Vermassen J, Huberlant V, Vinatier I, Anguel N, Levy M, Laterre PF; ASTONISH investigators. François B, et al. Lancet Respir Med. 2023 Oct;11(10):894-904. doi: 10.1016/S2213-2600(23)00158-3. Epub 2023 May 31. Lancet Respir Med. 2023. PMID: 37269870 Clinical Trial.
Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial.
François B, Lambden S, Garaud JJ, Derive M, Grouin JM, Asfar P, Darreau C, Mira JP, Quenot JP, Lemarié J, Mercier E, Lacherade JC, Vinsonneau C, Fivez T, Helms J, Badie J, Levy M, Cuvier V, Salcedo-Magguilli M, Laszlo-Pouvreau AL, Laterre PF, Gibot S; ESSENTIAL investigators. François B, et al. Among authors: asfar p. EClinicalMedicine. 2023 Jun;60:102013. doi: 10.1016/j.eclinm.2023.102013. Epub 2023 May 31. EClinicalMedicine. 2023. PMID: 37350989 Free PMC article.
Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle: The Limiting Acute Kidney Injury Progression In Sepsis Trial.
Gómez H, Zarbock A, Pastores SM, Frendl G, Bercker S, Asfar P, Conrad SA, Creteur J, Miner J, Mira JP, Motsch J, Quenot JP, Rimmelé T, Rosenberger P, Vinsonneau C, Birch B, Heskia F, Textoris J, Molinari L, Guzzi LM, Ronco C, Kellum JA. Gómez H, et al. Among authors: asfar p. Crit Care Explor. 2023 Aug 21;5(8):e0961. doi: 10.1097/CCE.0000000000000961. eCollection 2023 Aug. Crit Care Explor. 2023. PMID: 37614799 Free PMC article.
Prospective comparison of prognostic scores for prediction of outcome after out-of-hospital cardiac arrest: results of the AfterROSC1 multicentric study.
Lascarrou JB, Bougouin W, Chelly J, Bourenne J, Daubin C, Lesieur O, Asfar P, Colin G, Paul M, Chudeau N, Muller G, Geri G, Jacquier S, Pichon N, Klein T, Sauneuf B, Klouche K, Cour M, Sejourne C, Annoni F, Raphalen JH, Galbois A, Bruel C, Mongardon N, Aissaoui N, Deye N, Maizel J, Dumas F, Legriel S, Cariou A; AfterROSC Network. Lascarrou JB, et al. Among authors: asfar p. Ann Intensive Care. 2023 Oct 11;13(1):100. doi: 10.1186/s13613-023-01195-w. Ann Intensive Care. 2023. PMID: 37819544 Free PMC article.
Hypothermia vs Normothermia in Patients With Cardiac Arrest and Nonshockable Rhythm: A Meta-Analysis.
Taccone FS, Dankiewicz J, Cariou A, Lilja G, Asfar P, Belohlavek J, Boulain T, Colin G, Cronberg T, Frat JP, Friberg H, Grejs AM, Grillet G, Girardie P, Haenggi M, Hovdenes J, Jakobsen JC, Levin H, Merdji H, Njimi H, Pelosi P, Rylander C, Saxena M, Thomas M, Young PJ, Wise MP, Nielsen N, Lascarrou JB. Taccone FS, et al. Among authors: asfar p. JAMA Neurol. 2024 Feb 1;81(2):126-133. doi: 10.1001/jamaneurol.2023.4820. JAMA Neurol. 2024. PMID: 38109117
243 results